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A b s t r a c t  
Ethanolic and Aqueous extract of ArisaemaLeschenaultii was evaluated for its Antiulcer activity against 
naproxen induced ulcer. Different extracts of blume of A. leschenaultii gave dose dependent increase 
in anti-ulcer activity against naproxen induced ulcer. Ethanolic extract of blume of A. leschenaultii 
showed better ulcer inhibition (55.8%) as compared to AEAL (36.5%). The present investigation 
revealed that ArisaemaLeschenaultii exhibited significant antiulcer activity by enhancing antioxidant 
potential of gastric mucosa thereby reducing mucosal damage. 




Arisaemaleschenaultii (B.) AL. (Family Araceae) is commonly 
known as Dhei or Cobra Lilly. Itis widely distributed over the 
greater part of India on the hills of Assam, Karnataka, Kerala 
andTamilnadu. Different parts of plant are traditionally used in 
Ayurveda for the treatment of urinarydiseases, colitis, eczema, 
purging, gonorrhea, piles, haemorrhoids, syphills, roundworm, 
fistula 
and sinus [1]. The whole plant of this species has been reported to 
show antiseptic property inbuffaloes. Kumari et al., studied that AL 
is used as abortifacient and contraceptives for pig andcattle and 
also reported the 2method of preparing contraceptives from this 
plant[2]. Satyanarayanareported the fructosans is present in AL [3]. 
Material and methods 
Extraction Of Drug Material 
Plant material of A. leschenaultii was collected from different 
regions, thoroughly washed, and dried at 55ºC in an air dryer for 48 
h. Dried plant parts were powdered with Wiley Mill (Model 4276-M, 
Thomas Scientific, USA) to pass 20 mesh sieve and stored in 
sealed plastic bags. About 200 g of powdered material was taken 
and extracted with different techniques of extraction (soxhlet 
extraction, percolation, maceration, sonication, homogenization 
and microwave extraction) using different solvents (petroleum 
ether, benzene, chloroform, acetone, ethanol, methanol and 
water). Each process was repeated thrice for complete extraction. 
After extraction, extracts were combined and evaporated to 
dryness in vacuo.  
Anti-ulcer 
The present study deals with anti-ulcer activity of A. leschenaultii 
extracts in naproxen induced ulcer. The experimental setup of the 
study was given below. 
Experimental setup 
Group 1: Control group (10 mL/kg/day of saline) 
Group 2: Omeprazole (30 mg/kg p.o.)  
Group 3: EEAL (100 mg/kg/day in 1% CMC, p.o.) 
Group 4: EEAL (200 mg/kg/day in 1% CMC, p.o.) 
Group 5: AEAL (100 mg/kg/day in 1% CMC, p.o.) 
Group 6: AEAL (200 mg/kg/day in 1% CMC, p.o.) 
Naproxen induced ulcer 
One hour after drug treatment gastric ulcer was induced by the 
modified procedure [4]. Control was administered with 10 mL/kg of 
normal saline. Ethanolic and aqueous extracts (100 and 200 
mg/kg) were given to test groups. Omeprazole (30 mg/kg p.o.) was 
used as standard. One hour later naproxen (30 mg/kg p.o.) was 
administered. Animals were sacrificed after six hours of naproxen 
administration, stomach was isolated and opened along greater 
curvature to expose inner surface. Inner surface was washed 
thoroughly with normal saline. The ulcer area, ulcer index and 
percentage inhibition were calculated by using image analysis 
software [5]. 
Result and discussion 
Anti-ulcer activity 
The present study deals with anti-ulcer activity of A. leschenaultii 
extracts in naproxen induced ulcer. Naproxen is a non-steroidal 
anti-inflammatory drug (NSAID), which can directly damage the 
gastric epithelium by intracellularaccumulation of drug in an ionised 
state and reduce the hydrophobicity of the mucus gel layer by 
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enzymes such as catalase and glutathione peroxidase provide 
defence against damage of gastric mucosa after administration of 
NSAIDs and also decrease lipid peroxide level in rats [7& 5]. The 
ethanolic extracts of A. leschenaultii reduced lipid peroxide level by 
scavenging free radical and might increase the activity of anti-
oxidant enzymes (catalase and glutathione peroxidase). 
Neutrophil adherence to the endothelium of gastric microcirculation 
is critical in NSAID injury [8]. Neutrophil adherence damages the 
mucosa by liberating oxygen free radicals, releasing proteases and 
obstructing capillary blood flow. NSAIDs might induce the synthesis 
of tumour necrosis factor (TNFα) and leukotrienes and these 
inflammatory mediators stimulate neutrophil adherence by up-
regulation of adhesion molecules [9, 10 & 11]. The free radical 
scavenging effect, anti-TNFα activity, prostaglandins like protective 
action and leukotrienes inhibition by A. leschenaultii extracts might 
reverse the effect of neutrophil adherence. 
Gastric acid probably exacerbates NSAID injury by disrupting the 
basement membrane to produce deep injury, affecting platelet 
aggregation and impairing ulcer healing [12, 13 & 14]. Ethanolic 
extracts of A. leschenaultii is effective against first phase of 
inflammation, which occurs due to the release of histamine, 
serotonin and kinins. Thus, A. leschenaultii might reduce the 
secretion of gastric acid by blocking histamine receptor. 
Ulcer healing is a complex process that involves combination of 
wound retraction and re-epithelialization. It also involves growth 
factors and angiogenesis [15]. A. leschenaultii significantly reduced 
the size of ulcer.  
Table 1 shows the effect of A. leschenaultii extracts on naproxen 
induced ulcer. Our result showed that different extract of blume of 
A. leschenaultii gave dose dependent increase in anti-ulcer activity 
against naproxen induced ulcer. Ethanolic extract of blume of A. 
leschenaultii showed better ulcer inhibition (55.8%) as compared to 
AEAL (36.5%). The results were significant as compared to control 
(P<0.05). 
 The anti-ulcer activity of A. leschenaultii extracts might be due to 
antioxidant, anti-secretory, protective action and leukotrienes 
inhibition. The morphological representation of anti-ulcer activity of 
different extracts of A. leschenaultii is presented in Figure 1. 
 
Table 1: Effect of A. leschenaultiiblume extracts on naproxen  
induced ulcer. 
Groups Dose (mg/kg) US (mm2) UI % I 
Con - 7.34±0.22 1.23±0.04 - 
Omeprazole 30 2.54±0.09** 0.37±0.01** 80.90 
 
EEAL 
100 4.72±0.01** 0.73±0.01** 44.20 
200 4.05±0.52** 0.66±0.08* 55.80 
 
AEAL 
100 5.87±0.12 0.95±0.02* 31.10 
200 5.36±0.13** 0.88±0.06* 36.50 
 
US: Ulcer surface; UI: Ulcer index; % I: Percent inhibition. 
All values are expressed as mean ± SEM (n=6); One-way ANOVA followed by Dunnett's test; *P<0.05 and **P<0.01 considered             
significant as compared to control. 
 
Control 10 mL/kg                Omeprazole 30 mg/kg 
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EEAL 100 mg/kg                     EEAL 200 mg/kg 
 
AEAL 100 mg/kg     AEAL 200 mg/kg 
 
Figure 1: Morphological representation of anti-ulcer  
activity of A. leschenaultii. 
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